Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2709990 Title: DERIVES 1-((3-((1-PIPERAZINYL)PHENYL)METHYL)-2,4(1H,3H)-QUINAZOLINEDIONE EN TANT QU'INHIBITEURS DE PARP POUR LE TRAITEMENT DU CANCER V

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
127652303
WO application number:
CN2012073362
Type:
European patent granted for BE
Status:
Open
Publication number:
2709990
WO publication number:
WO2012130166
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
31/03/2012
Grant date:
12/06/2019
EP publication date:
26/03/2014
WO publication date:
04/10/2012
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
12/06/2019
EP B1 publication date:
12/06/2019
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
31/03/2032

Applicant

Name:
Impact Therapeutics, Inc.
Legal Form:
From:
12/06/2019
Address:
Floor 9 10 Xinghuo Road Nanjing, Jiangsu 210061, China (CN)
To:

Agent

Name:
JAEKEN Annemie
Legal Form:
From:
20/08/2019
Address:
Gaston Geenslaan 11, 3001, HEVERLEE, Belgium (BE)
To:

Inventor

1

Name:
CAI, Sui Xiong
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

2

Name:
TIAN, Ye Edward
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

3

Name:
DONG, Haijun
Legal Form:
Address:
Shanghai 201702, China (CN)

4

Name:
XU, Qingbing
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

5

Name:
WU, Lizhen
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

6

Name:
LIU, Lijun
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

7

Name:
JIANG, Yangzhen
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

8

Name:
BAO, Qingli
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

9

Name:
WANG, Guoxiang
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

10

Name:
YIN, Feng
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

11

Name:
GU, Chengyun
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

12

Name:
HU, Xiuhua
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

13

Name:
WANG, Xiaozhu
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

14

Name:
KANG, Sishun
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

15

Name:
CHEN, Shengzhi
Legal Form:
Address:
Nanjing Jiangsu 210061, China (CN)

Priority

1

Priority patent number:
201110082475
Priority date:
01/04/2011
Priority country:
China (CN)

2

Priority patent number:
PCT/CN2011/077034
Priority date:
11/07/2011
Priority country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:
A61K 31/517; A61P 9/00; A61P 35/00; C07D 239/96; C07D 401/06;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2019/18
Publication date:
03/07/2019
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
201924
Publication date:
12/06/2019
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/03/2026
Annual fee number:
15
Annual fee amount:
360 Euro
Expected payer:
Last annual fee payment date:
14/02/2025
Last annual fee paid number:
14
Last annual fee paid amount:
320 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
20/08/2019 General Document Other filed documents 2 PDF /0/3/6/5/6/0721865630/docs/127652303_0_generaldocument_20190821_082404500.pdf
20/08/2019 Incoming Correspondence (Email) Cover letter 2 PDF /0/3/6/5/6/0721865630/docs/127652303_1_incomingcorrespondenceelectronic_20190821_082406170.pdf
20/08/2019 Incoming Correspondence (Email) Cover letter 2 PDF /0/3/6/5/6/0721865630/docs/127652303_2_incomingcorrespondenceelectronic_20190821_082408389.pdf
20/08/2019 Outgoing Correspondence 1 PDF /0/3/6/5/6/0721865630/docs/127652303_3_outgoingcorrespondence_20190821_082402474.pdf